News

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.
Researchers are developing AI programmes to make doping detection more effective, faster, and cheaper. How do these systems ...